Journal
NEUROPHARMACOLOGY
Volume 183, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2020.108406
Keywords
Hemopressin; Cannabinoid; Endocannabinoid; Cannabinoid receptors
Categories
Funding
- Erna and Jakob Michael Visiting Professorship, Rehovot, Israel
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/04000-3, 2019/06982-6, 2017/24304-0]
- Brazilian National Research Council (CNPq) [302809/2016-3]
- Israel Science Foundation (ISF) [1247/15]
- WIS Minerva Center
- NIH [DA008863, NS026880]
- FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)
- INCT-INNT (National Institute of Translational Neuroscience) [465346/2014-6]
Ask authors/readers for more resources
Hemopressin, derived from hemoglobin alpha-chain, exhibits diverse cannabinoid receptor activities and may have pharmacological effects by interacting with intracellular mitochondrial cannabinoid receptors. The peptide influences physiological processes such as pain, inflammation, appetite, learning, and memory, and shows potential applications in drug delivery systems.
Hemopressin (PVNFKFLSH in rats, and PVNFKLLSH in humans and mice), a fragment derived from the alpha-chain of hemoglobin, was the first peptide described to have type 1 cannabinoid receptor activity. While hemopressin was shown to have inverse agonist/antagonistic activity, extended forms of hemopressin (i.e. RVD-hemopressin, also called pepcan-12) exhibit type 1 and type 2 cannabinoid receptor agonistic/allosteric activity, and recent studies suggest that they can activate intracellular mitochondrial cannabinoid receptors. Therefore, hemopressin and hemopressin-related peptides could have location-specific and biased pharmacological action, which would increase the possibilities for fine-tunning and broadening cannabinoid receptor signal transduction. Consistent with this, hemopressins were shown to play a role in a number of physiological processes including antinociceptive and anti-inflammatory activity, regulation of food intake, learning and memory. The shortest active hemopressin fragment, NFKF, delays the first seizure induced by pilocarpine, and prevents neurodegeneration in an experimental model of autoimmune encephalomyelitis. These functions of hemopressins could be due to engagement of both cannabinoid and non-cannabinoid receptor systems. Self-assembled nanofibrils of hemopressin have pH-sensitive switchable surface-active properties, and show potential as inflammation and cancer targeted drug-delivery systems. Upon disruption of the self-assembled hemopressin nanofibril emulsion, the intrinsic analgesic and anti-inflammatory properties of hemopressin could help bolster the therapeutic effect of anti-inflammatory or anti-cancer formulations. In this article, we briefly review the molecular and behavioral pharmacological properties of hemopressins, and summarize studies on the intricate and unique mode of generation and binding of these peptides to cannabinoid receptors. Thus, the review provides a window into the current status of hemopressins in expanding the repertoire of signaling and activity by the endocannabinoid system, in addition to their new potential for pharmaceutic formulations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available